ALRUD advised Pharmacy Chain 36.6 on various M&A transactions

ALRUD advised Pharmacy Chain 36.6 on various M&A transactions

10 January 2014

ALRUD advised Russian Pharmacy Chain 36.6 and its founding shareholders on all M&A transactions from 2000 to 2013, including the acquisition and sale of pharmacy chains, as well as the engaging of investors for the acquisition and subsequent sale of shares in the European Medical Centre (EMC) in Russia, the sale of a 52% stake in the pharmaceutical company Veropharm, and the exit of shareholders from this business.

As a consultant on Russian law, ALRUD experts also represented the Russian public company Pharmacy Chain 36.6 in a number of projects to raise financing from Russian and foreign banks.

The ALRUD team that worked on the projects under the leadership of Alexander Zharskiy (Partner and Head of Corporate and M&A Practice), Vassily Rudomino (Senior partner and Head of Antitrust Practice), and Kira Egorova (Counsel of Private Clients Practice) included representatives of the Corporate Practice: Counsel Oleg Ezhov, Senior Associate Sergey Khanaev, and Senior Associate of Private Clients Practice Ekaterina Vasina.

We use cookies to offer better performance of the website and fulfill some other purposes specified in the Privacy Policy. By way of ticking the box you provide your consent to use of cookies. Otherwise, we will only use technical cookies, which are necessary for proper functioning of the website.